The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,959.00
Bid: 2,950.00
Ask: 2,951.00
Change: 17.00 (0.58%)
Spread: 1.00 (0.034%)
Open: 2,950.00
High: 2,959.00
Low: 2,926.00
Prev. Close: 2,942.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM and portfolio update

30 Jun 2022 07:00

RNS Number : 7187Q
3i Group PLC
30 June 2022
 

30 June 2022

 

3i Group plc

AGM and portfolio update

 

3i Group plc ("3i") will be holding its Annual General Meeting ("AGM") this morning. At the AGM Simon Borrows, our Chief Executive, will provide an update on the portfolio.

 

Action has achieved very strong sales growth in the year to date. Like-for-like sales and footfall were significantly ahead of the prior year, although with a slightly reduced basket size. Inventory and supply chain continue to perform in line with plan with no significant issues despite the well documented global challenges. A clear and consistent focus on an outstanding quality customer offering at the lowest price continues to be Action's top priority and has never been more relevant to customers across all of its geographies. Action is set for another good quarter of profit growth to the end of June and closed last week with a cash balance of some €550 million.

 

The remainder of the Private Equity portfolio continues to demonstrate overall resilience with the majority of the portfolio continuing to build on recent growth including Cirtec, Sanisure, nexeye (formerly Hans Anders), Tato, Havea, WilsonHCG and Yanga. As would be expected given current market conditions, a small number of companies in the portfolio are having to manage a combination of lower customer demand and inflationary pressures. 

 

Despite short-term market volatility and macro-economic uncertainty our portfolio is well positioned and we increasingly see attractive opportunities to deploy capital. We remain confident in 3i's potential to deliver significant longer-term compounding returns.

 

-Ends-

 

For further information, please contact:

Silvia SantoroGroup Investor Relations DirectorTel: 020 7975 3258

 

Kathryn van der KroftCommunications DirectorTel: 020 7975 3021

 

 

About 3i Group

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGZVNLZGZZM
Date   Source Headline
31st Jul 20203:41 pmRNSTotal Voting Rights
31st Jul 20202:40 pmRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSQ1 performance update
16th Jul 20202:22 pmRNSPortfolio Update
1st Jul 20203:00 pmRNSDirector/PDMR Shareholding
30th Jun 20204:17 pmRNSTotal Voting Rights
30th Jun 20204:17 pmRNSDirector/PDMR Shareholding
30th Jun 20202:08 pmRNSDirector/PDMR Shareholding
26th Jun 20205:03 pmRNSDirector/PDMR Shareholding
25th Jun 20204:12 pmRNSDirector/PDMR Shareholding
25th Jun 202012:55 pmRNSResult of AGM
25th Jun 202012:54 pmRNSDoc re. AGM Resolutions
18th Jun 20209:00 amRNSDirector/PDMR Shareholding
11th Jun 202010:39 amRNSBlock listing Interim Review
10th Jun 20202:52 pmRNSDirector/PDMR Shareholding
3rd Jun 20201:30 pmRNSDirector/PDMR Shareholding
3rd Jun 202012:00 pmRNSPublication of a Prospectus
29th May 20204:03 pmRNSTotal Voting Rights
29th May 20204:02 pmRNSDirector/PDMR Shareholding
29th May 202010:37 amRNSDTR 6.3.5
27th May 202011:04 amRNSDoc re. 2020 Notice of AGM
20th May 202010:55 amRNSDoc re. 2020 Annual Report and Accounts
14th May 20207:00 amRNSResults for the year to 31 March 2020
30th Apr 20203:09 pmRNSTotal Voting Rights
30th Apr 20203:08 pmRNSDirector/PDMR Shareholding
1st Apr 202010:02 amRNSDirector/PDMR Shareholding
30th Mar 20209:39 amRNSDirector/PDMR Shareholding
30th Mar 20209:38 amRNSDirector/PDMR Shareholding
19th Mar 20208:30 amRNSCovid-19 update and Action Seminar
10th Mar 20202:28 pmRNSHolding(s) in Company
28th Feb 20204:10 pmRNSTotal Voting Rights
28th Feb 20204:07 pmRNSDirector/PDMR Shareholding
20th Feb 202011:30 amRNSHolding(s) in Company
4th Feb 20203:56 pmRNSHolding(s) in Company
31st Jan 20204:18 pmRNSTotal Voting Rights
31st Jan 20204:15 pmRNSDirector/PDMR Shareholding
30th Jan 20207:00 amRNSFY2020 Q3 Performance update
7th Jan 202011:51 amRNSPortfolio Update
3rd Jan 20203:18 pmRNSTotal Voting Rights
3rd Jan 20203:15 pmRNSDirector/PDMR Shareholding
2nd Jan 202011:47 amRNSDirectorate Change
17th Dec 20194:02 pmRNSDirector/PDMR Shareholding
11th Dec 201910:48 amRNSBlock listing Interim Review
3rd Dec 201912:00 pmRNSDirector/PDMR Shareholding
29th Nov 20193:17 pmRNSTotal Voting Rights
29th Nov 20193:13 pmRNSDirector/PDMR Shareholding
14th Nov 20191:39 pmRNSDoc re. Half Yearly Report 2019
14th Nov 20197:00 amRNSHalf-year Report
31st Oct 20192:52 pmRNSTotal Voting Rights
31st Oct 20192:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.